anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

231,781-231,840 of 319,975

filter-aware
01
Slide 1
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
02
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
03
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a grid layout to present six distinct value propositions for the company.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
05
The slide uses a standard pharmaceutical pipeline visualization format.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Roadmap1 hit
06
The slide uses a four-column layout to structure the disease landscape.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
07
Uses a Venn/concentric circle diagram to show the funnel from total infected to diagnosed to treated.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Problem StatementLoop · Aha Moment1 hit
08
The slide uses a process-oriented flow diagram to explain the therapeutic strategy.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Aha Moment1 hit
09
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
10
The slide highlights the mechanism of action and key benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
11
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Key Takeaways1 hit
12
The slide outlines a clinical trial protocol with specific patient counts (n=43, 12, 13, 8, 10) and timeline milestones (weeks 1, 24, 28, 40, 52).Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
13
Data presented at EASL 2024. Includes specific patient counts and percentages for Cohorts A1 and A2.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
14
Data presented at EASL 2024. LLOQ = 0.05 IU/mL.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
15
The slide outlines two parallel study arms involving Imdusiran, VTP-300, NA, and Nivolumab.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
16
Data presented at EASL 2024. Includes stacked bar charts for threshold achievement and line chart for mean levels over 72 weeks.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
17
Data presented at EASL 2024. Includes pie charts comparing Group A and Group B across three metrics: time off NA therapy, HBV DNA levels, and HBsAg levels.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
18
The slide outlines a clinical trial structure with three cohorts (A, B, C) and a follow-up period, totaling 48 weeks.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
19
The slide details a specific licensing deal with financial terms and geographic scope.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
20
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
21
The slide uses a three-column layout to explain the scientific basis and product profile of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
22
Includes both in vitro (IFN-y fold increase) and in vivo (MC38 tumor model) efficacy data.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
23
The slide uses a process flow diagram to illustrate the sequential dosing cohorts in a clinical trial setting.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
24
Includes a diagram showing the split of royalties/damages between Arbutus and Genevant.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
25
The slide uses checkmarks to indicate completed milestones within the 1H 2024 period.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
26
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
01
Slide 1
Includes brand logos and a date.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations 1 hit
02
The slide uses a scenic background image and numbered list to structure the presentation flow.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · Problem1 hit
03
The slide uses a large number '1' and a headline to signal a new section.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · Problem1 hit
04
The slide serves as a brand alignment or partnership statement.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · Problem1 hit
05
The slide uses three distinct cultural images (Einstein, Big Ben, The Slap) to illustrate the impact of visual media.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · Problem1 hit
06
The slide serves as a visual break, likely demonstrating the power of imagery.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations 1 hit
07
The slide uses a famous historical photograph as a visual analogy for the company's value proposition.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations 1 hit
08
The slide uses the iconic 'Lunch atop a Skyscraper' photo to establish an emotional connection or context.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations 1 hit
09
The slide uses a high-impact photograph to evoke emotion and capture a 'big moment', likely serving as a transition or to set a tone of excellence/achievement.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations 1 hit
10
The slide is a visual demonstration of generative AI capabilities.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations 1 hit
11
Getty | Investor Presentation Deck | 48 slidesGetty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations 1 hit
12
Uses four metrics to establish market context and urgency.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Loop · Why Now1 hit
13
The slide uses a large '2' as a visual anchor for the section number.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
14
The slide uses a numbered list format with hexagonal icons.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
15
Getty | Investor Presentation Deck | 48 slidesGetty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
16
The slide uses a comparison matrix to differentiate the three brands within the company's portfolio.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
17
The slide uses a combination of bar charts, donut charts, and descriptive blocks to illustrate the business model.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
18
The slide highlights three pillars of the creative offering: library scale, custom content network, and research/expertise.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
19
This slide serves as a visual break or transition, likely used to evoke themes of adventure, intensity, or diverse experiences.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
20
Stock photo used as a filler or transition slide.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
21
The slide uses a vertical column layout to categorize competitive advantages.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Loop · Why Now1 hit
22
This slide serves as a visual mood board or filler, likely representing the breadth of content available via Getty Images/iStock/Unsplash.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Loop · Why Now1 hit
23
The slide uses a circular flywheel diagram to show the virtuous cycle of content creation, customer engagement, and revenue conversion.Getty | Investor Presentation Deck | 48 slides · Getty Images
Pitch deck Investor relations Loop · Why Now1 hit
20
Uses a 'deal' framing to appeal to shareholder fairness and fiduciary consistency.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations 1 hit
21
Uses a before-after framing to address shareholder concerns.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations 1 hit
22
The slide uses a dark, high-contrast aesthetic typical of Tesla's corporate communications.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
23
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
24
This slide is part of a defense strategy to preemptively rebut concerns about board independence.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
25
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
26
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
27
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
28
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
29
This is a web page screenshot acting as a navigation hub for investor materials.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
30
The slide consists of a tweet by whatsupfranks and a reply by Elon Musk.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit